Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feigenbaum

Showing results (251-260 of 1,030) with videos related to

Pageof 103
Sort By:
The New England Journal of Medicine|October 24, 1974
Letter: Feminization in male alcoholicsP A Feigenbaum, C E Becker
Chest|July 1, 1975
Condensed M-mode echocardiograhpic scan of the symmetrical left ventricleS Chang, H Feigenbaum, J Dillion
Neuroscience Letters|October 25, 1996
Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis studyJ J Feigenbaum, S G Howard
Progress in Neurobiology|September 1, 1996
Gamma hydroxybutyrate is not a GABA agonistJ J Feigenbaum, S G Howard
Journal of Inherited Metabolic Disease|November 5, 1997
Phenotypically mild presentation in a patient with 2-methylacetoacetyl-coenzyme A (beta-keto)thiolase deficiencyK M Gibson, A S Feigenbaum
The International Journal of Neuroscience|November 1, 1996
Does gamma-hydroxybutyrate inhibit or stimulate central DA release?J J Feigenbaum, S G Howard
American Heart Journal|April 13, 2004
Challenge of identifying patients with diabetes mellitus who are at low risk for coronary events by use of cardiac stress imagingMasoor Kamalesh, Harvey Feigenbaum, Stephen Sawada
The International Journal of Neuroscience|November 1, 1982
Possible DA agonist properties of naloxoneJ Feigenbaum, J Yanai, R Blass
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor functionP Feigenbaum, E E El-Fakahany
Optics Letters|February 25, 2006
Circulating spatial solitonsEyal Feigenbaum, Meir Orenstein, Jacob Schceuer
Pageof 103

Showing results (251-260 of 1,030) with videos related to

Sort By:
Pageof 103
The New England Journal of Medicine|October 24, 1974
Letter: Feminization in male alcoholicsP A Feigenbaum, C E Becker
Chest|July 1, 1975
Condensed M-mode echocardiograhpic scan of the symmetrical left ventricleS Chang, H Feigenbaum, J Dillion
Neuroscience Letters|October 25, 1996
Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis studyJ J Feigenbaum, S G Howard
Progress in Neurobiology|September 1, 1996
Gamma hydroxybutyrate is not a GABA agonistJ J Feigenbaum, S G Howard
Journal of Inherited Metabolic Disease|November 5, 1997
Phenotypically mild presentation in a patient with 2-methylacetoacetyl-coenzyme A (beta-keto)thiolase deficiencyK M Gibson, A S Feigenbaum
The International Journal of Neuroscience|November 1, 1996
Does gamma-hydroxybutyrate inhibit or stimulate central DA release?J J Feigenbaum, S G Howard
American Heart Journal|April 13, 2004
Challenge of identifying patients with diabetes mellitus who are at low risk for coronary events by use of cardiac stress imagingMasoor Kamalesh, Harvey Feigenbaum, Stephen Sawada
The International Journal of Neuroscience|November 1, 1982
Possible DA agonist properties of naloxoneJ Feigenbaum, J Yanai, R Blass
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor functionP Feigenbaum, E E El-Fakahany
Optics Letters|February 25, 2006
Circulating spatial solitonsEyal Feigenbaum, Meir Orenstein, Jacob Schceuer
Pageof 103